Phase 2 trial of lenvatinib at 2 starting doses + everolimus in renal cell carcinoma (RCC). Presented at 19th Annual Meeting of the International Kidney Cancer Symposium (IKCS 2020); November 6–7, 2020 - Pal, SK; Puente, J; Heng, DYC
et al.